WESTBURY, N.Y.--(BUSINESS WIRE)--Vasomedical, Inc. (“Vasomedical”) (OTC: VASO.OB - News), a world leader in the noninvasive treatment of cardiovascular diseases, today announced that the United States Patent and Trademark Office has issued a new patent to Vasomedical on January 1, 2008. This new patent, US 7,314,478 B2 is for technology that automatically controls and precisely maintains the inflation and deflation pressures within the cuffs during enhanced external counterpulsation therapy. The patent also provides for a method to automatically release all applied pressure to the atmosphere in the event of a system or power failure as a safety measure to avoid injury to the patient.
